ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,040.53
-0.50%
US Tech 100
20,778.00
-0.69%
다우존스 지수
44,544.66
-0.75%
Bitcoin
101,803.01
-0.60%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Zymeworks Inc (ZYME) 시세

Zymeworks Inc

Zymeworks Inc (ZYME)

NASDAQ
14.60
-0.14
(-0.95%)
마감 01 2월 6:00AM
15분 지연
14.60
0.00
(0.00%)
시간외 거래: 9:50AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
14.60
매수가
13.89
매도가
14.67
거래량
277,596
14.48 일간 변동폭 14.97
7.97 52주 범위 17.70
market_cap
1.006B
전일 종가
14.74
개장가
14.77
최근 거래 시간
150
@
14.6
(formt)
마지막 거래 시간
재정 규모
US$ 4,082,022
VWAP
14.7049
평균 볼륨(3m)
465,873
발행 주식
68,877,526
배당수익률
-
주가수익률
-8.47
주당순이익(EPS)
-1.72
매출
76.01M
순이익
-118.67M

Zymeworks Inc 정보

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.zymeworks.com
본부
Wilmington, Delaware, USA
설립됨
-
Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ZYME. The last closing price for Zymeworks was US$14.74. Over the last year, Zymeworks shares have traded in a share price range of US$ 7.97 to US$ 17.70.

Zymeworks currently has 68,877,526 shares in issue. The market capitalisation of Zymeworks is US$1.02 billion. Zymeworks has a price to earnings ratio (PE ratio) of -8.47.

ZYME 최신 뉴스

추가 뉴스

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

30 1월 2025
GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

14 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 1월 2025
Edgar (US Regulatory)

Form 8-K - Current report

09 1월 2025
Edgar (US Regulatory)

Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026

Investigational new drug (IND) applications for initiating first-in-human studies for ZW220 and ZW251 in solid tumors anticipated in 2025IND applications for initiating first-in-human studies for...

09 1월 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

07 1월 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

07 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 12월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 12월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 12월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.03-0.20505809979514.6315.0814.2626267814.56771487CS
4-1.9065-11.549995456316.506516.506512.841630614.2009005CS
12-2.06-12.364945978416.6617.712.4346587314.3922123CS
264.1139.18017159210.4917.79.40558004012.86566978CS
523.8235.435992578810.7817.77.9759703311.28867657CS
1568.22128.8401253926.3817.76.0156133839.73787306CS
2608.22128.8401253926.3817.76.0156133839.73787306CS

ZYME - Frequently Asked Questions (FAQ)

What is the current Zymeworks share price?
The current share price of Zymeworks is US$ 14.60
How many Zymeworks shares are in issue?
Zymeworks has 68,877,526 shares in issue
What is the market cap of Zymeworks?
The market capitalisation of Zymeworks is USD 1.02B
What is the 1 year trading range for Zymeworks share price?
Zymeworks has traded in the range of US$ 7.97 to US$ 17.70 during the past year
What is the PE ratio of Zymeworks?
The price to earnings ratio of Zymeworks is -8.47
What is the cash to sales ratio of Zymeworks?
The cash to sales ratio of Zymeworks is 13.23
What is the reporting currency for Zymeworks?
Zymeworks reports financial results in USD
What is the latest annual turnover for Zymeworks?
The latest annual turnover of Zymeworks is USD 76.01M
What is the latest annual profit for Zymeworks?
The latest annual profit of Zymeworks is USD -118.67M
What is the registered address of Zymeworks?
The registered address for Zymeworks is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Zymeworks website address?
The website address for Zymeworks is www.zymeworks.com
Which industry sector does Zymeworks operate in?
Zymeworks operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
872.46k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.54M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
338.75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.29M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
234.8M

토론

전체 피드 보기
trader53 trader53 5 분 전
DPLS - "Short Squeeze" Explained


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636946062923800000

________________________________________________


DPLS
bbotcs bbotcs 6 분 전
lj: This type of journalism can start a panic in the market: https://www.dailymail.co.uk/news/article-14348965/Hedge-funds-massive-bet-stock-market-crash-raises-alarm.html
nowwhat2 nowwhat2 9 분 전
Oh-oh

https://investorshub.advfn.com/uimage/uploads/2025/2/1/cbbliBTC_@_1_15D_GLITCH_HELP_MAG_100K.jpg

101,888





Spidey senses.......

Jumbo glitch
BTCUSD
pgsd pgsd 11 분 전
MSD (Merck) Ireland announces acquisition of WuXi Vaccines’ Dundalk site

MSD's acquisition of the WuXi Vaccines Dundalk site strengthens the company’s long-standing commitment to Ireland, bringing its footprint to eight locations nationwide with over 3,000 currently employed across th
NWBO
threewheeler threewheeler 21 분 전
KRTLBIOTECH OTC:KRTL
@KRTLBiotech
Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
8:45 PM · Jan 31, 2025
·
341
Views
KRTL
threewheeler threewheeler 22 분 전
KRTLBIOTECH OTC:KRTL
@KRTLBiotech
Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
8:45 PM · Jan 31, 2025
·
341
Views
KRTL
threewheeler threewheeler 22 분 전
KRTLBIOTECH OTC:KRTL
@KRTLBiotech
Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
8:45 PM · Jan 31, 2025
·
341
Views
KRTL
Drugdoctor Drugdoctor 27 분 전
Well, once a company takes over a shell, and changes the name to their new company, previous owners will quickly be forgotten. It's up to the new company to do their own image building. I think there was more than the problem with the holligans at play here.
GVSI
Looking4aprofit Looking4aprofit 27 분 전
Further to the post, I asked Gemini about this ruling and Discovery :

Yes, this ruling will likely lead to discovery, at least regarding the claims that survived the motion to dismiss.

Here's why:

Motion to Dismiss Stage: The document you provided is rela
NWBO
dhyan40 dhyan40 28 분 전
The Silver Suppression and Systemic Risk
Silver continues to be a key industrial and monetary asset. The current gold-to-silver ratio stands at 88:1 - significantly above historical norms of 16:1 - prompting discussions around price alignment. With a four-year supply deficit and increasing in
LEHNQ
nowwhat2 nowwhat2 30 분 전
I so showed you this was coming....
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175568712

https://investorshub.advfn.com/uimage/uploads/2025/2/1/ijevsplby_121212_17_w__cup__girl.jpg

That was on December 16th
Jan 31 NEWS https://www.mark
PLBY
Seminole Red Seminole Red 35 분 전
Amy Klobuchar Attempts To Set A Trap For Kash Patel. It Does Not Go Well.

Patel asked Committee Chair Sen. Chuck Grassley (R-IA) for extra time, after which Klobuchar interrupted and repeatedly demanded that Patel answer her question.

Instead, Patel was given a moment t
jimjet218 jimjet218 42 분 전
Your two BIG issues are not "BIG" to some of us.

As you yourself said the interaction between the potential "partners" is about data. You are correct in that we don't and can't know when the data will be enough. Could be weeks could be months. I don't see it as a BIG issue. Data,
LWLG
4u2nv2 4u2nv2 47 분 전
My credibility was in question because of what time of the day or night I post comments? Here is a comment for you - There are no paid bashers here and no one is in a short position on IFUS. Here is what I see, a bunch of insiders at IFUS or people connected to them that are pointing their middle fi
IFUS
JesterHaven311 JesterHaven311 49 분 전
Quite a few at AGSM. All resolutions passed including share consolidation. Hopefully we get more interest from II. Murphy is hanging on 😁and sale of LLP also went through 👋👋👋 So 284,362 CRML shares in the bank on 28 feb. So if CRML price stays the same as yesterday ($
REZZF
Bsparks11 Bsparks11 52 분 전
Best idea I’ve heard in years. You’re onto something here bee. Let’s get ninja to bankroll. 😉
GAHC
Bsparks11 Bsparks11 53 분 전
Buy Ninja, buy!!! lol. 😂
GAHC
Bsparks11 Bsparks11 54 분 전
Buy Ninja, buy!!! lol. 😂
GAHC
Seminole Red Seminole Red 59 분 전
Gusts approaching 30 mph are in the forecast, along with spots of rain. Pebble Beach, that felicitous meeting of land and sea, is a beast in nasty weather.
MoCubano MoCubano 1 시간 전
Excellent!
FNMA
Kam8 Kam8 1 시간 전
I thought MMs would like to pay Billion to nwbo instead of discovery. 
NWBO
Seminole Red Seminole Red 1 시간 전
I have 4- 8's, wish we were playing poker...
Golfbum22 Golfbum22 1 시간 전
Another expert put on ignore
FNMA
Looking4aprofit Looking4aprofit 1 시간 전
Of course he would show up…he is NWBO shareholders’ guardian angel, has no shares but here (24/7) to protect us from the “incompetent “ management and forestall us from continuing to support a “failed trial” company! Thanks Jerry for your altruistic endeavours.

Don’t act the fool Jer
NWBO
Money hunt Money hunt 1 시간 전
With TTX Ai platform, Yes RNAZ can
Can Trump-backed Stargate project beat ‘The Big C’?

The tech is expected to help create a cancer vaccine in just 48 hours.

US President Donald Trump has unveiled a $500b joint venture among Oracle Corp., OpenAI, and Softbank Gro
RNAZ

최근 히스토리

NASDAQ
ZYME
Zymeworks
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지